Women smokers have higher risk of lung cancer than men smokers, though lower lung cancer death rate

July 11, 2006

Women who smoke appear to be more susceptible to lung cancer than men who smoke, though women smokers have a lower rate of lung cancer-related death, according to a study in the July 12 issue of JAMA.

In 2006 in the United States, it is estimated that lung cancer will cause 73,020 deaths in women, proportionately only slightly fewer than the estimated 90,470 deaths in men. Lung cancer now accounts for more deaths in women than any other cancer, more even than the second and third cancer killers (breast and colon cancer) combined, according to background information in the article. It has been hypothesized that women are more susceptible to tobacco carcinogens than men, but after diagnosis of lung cancer, they have better survival rates than men.

Claudia I. Henschke, Ph.D., M.D., of Cornell University, New York, and investigators with the International Early Lung Cancer Action Program examined the lung cancer risk of women compared with men, accounting for age and history of smoking, and also compared the rate of fatal outcomes between sexes. The study included 7,498 women and 9,427 men, at least 40 years of age, who had a history of cigarette smoking and were screened for lung cancer in North America between 1993-2005.

Lung cancer was diagnosed in 156 women and 113 men (rates of 2.1 percent and 1.2 percent, respectively). The researchers also found that women had a lower rate of lung cancer-related death, when controlling for pack-years of smoking, disease stage, tumor cell type and resection.
Editorial: Women and Lung Cancer - Gender Equality at a Crossroad?

In an accompanying editorial, Alfred I. Neugut, M.D., Ph.D., and Judith S. Jacobson, Dr.P.H., M.B.A., of Columbia University, New York, comment on the study by Henschke et al.

"If lung cancer risk for women who smoke is indeed higher than the risk for men of the same age who smoke, as indicated by the evidence presented here, this suggests that antismoking efforts directed toward girls and women need to be even more serious than those directed toward boys and men," the authors write. (JAMA. 2006;296:180-184. Available pre-embargo to the media at www.jamamedia.org)

"The reasons women live with lung cancer longer than men are unclear," they write. "Do women fare better because of their body size, better health behaviors, hormonal and reproductive factors, different cigarette smoking histories or patterns, or other factors? Women's stage-for-stage advantage in survival appears to be a host effect and applies to all the major histological types of lung cancer."

"The once prevalent adage, 'You've come a long way, Baby!' geared to female smokers, unfortunately now applies to increased smoking prevalence and lung cancer risk among women. To prevent gender equality in lung cancer from becoming a reality, it's now time to turn back." (JAMA. 2006;296:218-219. Available pre-embargo to the media at www.jamamedia.org)

The JAMA Network Journals

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.